Age (y) | 55 ± 19 |
Body surface area (m2) | 1.88 ± 0.21 |
Men (%) | 71 |
Heart rate (bpm) | 67 ± 13 |
LV end-diastolic volume (ml/m2) | 82 ± 26 |
LV end-systolic volume(ml/m2) | 33 ± 22 |
LV ejection fraction (%) | 62 ± 12 |
LV mass (g/m2) | 68 ± 19 |
RV end-diastolic volume (ml/m2) | 75 ± 20 |
RV end-systolic volume (ml/m2) | 27 ± 11 |
RV ejection fraction (%) | 64 ± 8 |
Clinical indication to cardiac magnetic resonance (n, %) | Â |
 Ischaemic heart disease/myocardial viability | 32 (29.6) |
 Assessment of cardiomyopathy phenotype | 58 (53.7) |
 Assessment of causation of heart failure | 16 (14.8) |
 Valvular heart disease | 2 (1.9) |